Prospera Financial Services Inc Fulgent Genetics, Inc. Transaction History

Prospera Financial Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$47.98 - $62.75 $6,045 - $7,906	-126 Reduced 62.38%	76 $4,000
Q1 2022 May 04, 2022	BUY	$49.85 - $96.11 $10,069 - $19,414	202 New	202 $13,000
Q4 2021 Feb 10, 2022	SELL	$77.3 - $105.0 $227,571 - $309,120	-2,944 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $220,417 - $326,401	2,944 New	2,944 $265,000
Q2 2021 Aug 12, 2021	SELL	$66.8 - $100.45 $148,296 - $222,999	-2,220 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$59.3 - $183.85 $131,646 - $408,147	2,220 New	2,220 $214,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.